Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut
About Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
3
Pfizer
3
Clinical Trials at Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut
During the past decade, Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on
average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications
2018-01-21
2020-08-24
Terminated
553
A Study of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) Infection
2021-11-17
2022-03-31
Terminated
5
A Study of Acute Respiratory Infections in Global Outpatient Setting
2021-12-20
2023-04-27
Recruiting
2,960
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut
According to Clinical.Site data, the most researched conditions in "Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut" are
"Cardiovascular Disease" (2 trials), "Acute Respiratory Infection" (1 trials), "Clostridium Difficile Infection" (1 trials), "Influenza A" (1 trials) and "Respiratory Syncytial Virus" (1 trials). Many other conditions were trialed in "Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut" in a lesser frequency.
Clinical Trials Intervention Types at Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut
Most popular intervention types in "Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut" are "Drug" (4 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "bococizumab (PF-04950615)" (2 trials), "Clostridium difficile vaccine" (1 trials), "Nasal Swab Sample" (1 trials) and "Pimodivir 600 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut
The vast majority of trials in "Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut" are
6 trials for "All" genders.
Clinical Trials Status at Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut
Currently, there are NaN active trials in "Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".